SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
+41.76%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$164M
AUM Growth
+$164M
(+90%)
Cap. Flow
+$29M
Cap. Flow
% of AUM
17.7%
Top 10 Holdings %
Top 10 Hldgs %
48.71%
Holding
75
New
26
Increased
18
Reduced
14
Closed
15
Top Buys
| 1 |
Zymeworks
ZYME
|
$13M |
| 2 |
AstraZeneca
AZN
|
$7.2M |
| 3 |
Prothena Corp
PRTA
|
$7.06M |
| 4 |
QuidelOrtho
QDEL
|
$6.91M |
| 5 |
Sarepta Therapeutics
SRPT
|
$5.53M |
Top Sells
| 1 |
Larimar Therapeutics
LRMR
|
$16.9M |
| 2 |
Grifois
GRFS
|
$7.8M |
| 3 |
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
|
$7.29M |
| 4 |
Zynex
ZYXI
|
$4.28M |
| 5 |
AGN
Allergan plc
AGN
|
$2.59M |
Sector Composition
| 1 | Healthcare | 95.78% |
| 2 | Real Estate | 0.92% |
| 3 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Zymeworks
ZYME
$1.12B
| $15.2M | 8.65% | 420,836 +359,308 | +584% | +$13M |
|
2
ESSA Pharma
EPIX
$11.4M
| $12.9M | 7.36% | 2,082,185 +1,764 | +0.1% | +$10.9K |
|
|
ISEE
3
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $8.3M | 4.73% | 1,626,701 +19,548 | +1% | +$99.7K |
|
|
4
AstraZeneca
AZN
$248B
| $7.2M | 4.11% | +136,214 | New | +$7.2M |
|
|
5
Prothena Corp
PRTA
$441M
| $7.06M | 4.02% | +674,603 | New | +$7.06M |
|
|
6
QuidelOrtho
QDEL
$1.95B
| $6.91M | 3.94% | +30,900 | New | +$6.91M |
|
|
EIGR
7
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $5.95M | 3.39% | 620,266 +215,059 | +53% | +$2.06M |
|
|
ALXN
8
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $5.7M | 3.25% | 50,789 +2,989 | +6% | +$335K |
|
|
9
Sarepta Therapeutics
SRPT
$1.78B
| $5.53M | 3.15% | +34,500 | New | +$5.53M |
|
10
iRadimed
IRMD
$921M
| $4.93M | 2.81% | 212,436 -22,374 | -10% | -$519K |
|
11
Adverum Biotechnologies
ADVM
$64.6M
| $4.57M | 2.6% | 218,723 -95,177 | -30% | -$1.99M |
|
|
12
Zynex
ZYXI
$49.7M
| $4.39M | 2.5% | 176,541 -172,023 | -49% | -$4.28M |
|
|
IMMU
13
DELISTED
Immunomedics Inc
IMMU
| $4.22M | 2.4% | +119,000 | New | +$4.22M |
|
14
DexCom
DXCM
$29.5B
| $3.87M | 2.21% | 9,550 -3,900 | -29% | -$1.58M |
|
15
Spyre Therapeutics
SYRE
$996M
| $3.42M | 1.95% | 369,852 -166,645 | -31% | -$1.54M |
|
16
Eli Lilly
LLY
$657B
| $3.41M | 1.95% | +20,800 | New | +$3.41M |
|
17
NovoCure
NVCR
$1.38B
| $3.34M | 1.91% | 56,397 +50,800 | +908% | +$3.01M |
|
18
Vericel Corp
VCEL
$1.83B
| $3.3M | 1.88% | 238,532 -113,800 | -32% | -$1.57M |
|
|
NARI
19
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $3.19M | 1.82% | +65,817 | New | +$3.19M |
|
20
Xenon Pharmaceuticals
XENE
$2.98B
| $3.15M | 1.79% | 250,897 +237,669 | +1,797% | +$2.98M |
|
21
AbbVie
ABBV
$372B
| $2.84M | 1.62% | 28,900 +2,400 | +9% | +$236K |
|
|
MSON
22
DELISTED
Misonix Inc
MSON
| $2.66M | 1.52% | 196,301 -42,032 | -18% | -$570K |
|
|
ITMR
23
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $2.61M | 1.49% | 140,524 +25,659 | +22% | +$477K |
|
24
OraSure Technologies
OSUR
$242M
| $2.6M | 1.48% | +223,200 | New | +$2.6M |
|
25
Humana
HUM
$36.5B
| $2.56M | 1.46% | +6,600 | New | +$2.56M |
|